2018
DOI: 10.19070/2377-8075-18000122
|View full text |Cite
|
Sign up to set email alerts
|

Pfeiffer Syndrome Type 1: A Case Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Six of the female patients had a history of hormone changes, including pregnancy, hormone therapy, and gynecological treatment. Two females developed MICRR during pregnancy (Chen et al, 2020;Ge & Wang, 2013), two experienced worsening of the MICRR after pregnancy (George & Miller, 1986;Liang et al, 2003), while two developed MICRR after hormone therapy or gynecological surgery (Kerr et al, 1970;Lydiatt et al, 1989), so we propose that the occurrence and progression of MICRR may be related to hormone changes in females. Deeb et al (2019) reported that one patient developed MICRR after denosumab discontinuation and proposed the "rebound effect hypothesis."…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…Six of the female patients had a history of hormone changes, including pregnancy, hormone therapy, and gynecological treatment. Two females developed MICRR during pregnancy (Chen et al, 2020;Ge & Wang, 2013), two experienced worsening of the MICRR after pregnancy (George & Miller, 1986;Liang et al, 2003), while two developed MICRR after hormone therapy or gynecological surgery (Kerr et al, 1970;Lydiatt et al, 1989), so we propose that the occurrence and progression of MICRR may be related to hormone changes in females. Deeb et al (2019) reported that one patient developed MICRR after denosumab discontinuation and proposed the "rebound effect hypothesis."…”
Section: Discussionmentioning
confidence: 93%
“…Functional studies have suggested that this mutation may inhibit IRF8 expression and weaken IRF8 protein function to promote osteoclasts generation at the transcription level and increase the risk for root resorption (Thumbigere-Math et al, 2019). In addition, MICRR or development of new lesions was observed in six female patients undergoing hormonal changes, including pregnancy, hormone therapy, or gynecological treatment (Chen et al, 2020;Ge & Wang, 2013;George & Miller, 1986;Kerr et al, 1970;Liang et al, 2003;Lydiatt et al, 1989), which indicates that hormonal changes in female patients may be related to MICRR.…”
Section: Predisposing Factorsmentioning
confidence: 99%